Cardiovascular Geneticists specialize in understanding how inherited genetic factors influence the risk and development of heart and blood vessel diseases. By analyzing family history alongside advanced genetic testing, these experts identify mutations and hereditary conditions that may predispose individuals to disorders such as arrhythmias, aneurysms, or sudden cardiac events. Their work enables early detection of genetic risks, allowing patients and their families to receive personalized counseling and preventive care before symptoms arise. This proactive approach can guide decision-making about lifestyle adjustments, medical surveillance, and treatment options tailored to each patient’s unique genetic profile.
These specialists often collaborate closely with other healthcare providers to integrate genetic insights into comprehensive care plans. They help interpret complex test results and provide education to patients about the implications for themselves and their relatives. In addition to assessing inherited conditions, their research contributes to the development of new therapies targeting specific genetic pathways. By bridging the gap between genetics and clinical care, these experts offer a crucial perspective that enhances prevention, diagnosis, and management of hereditary cardiovascular conditions. Their work empowers patients with knowledge and tools to better manage their health risks and supports ongoing advancements in precision medicine. With their specialized expertise, they play a vital role in shaping the future of personalized healthcare.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico